Comparison
5-HT1A receptor agonists (e.g., 8-OH-DPAT) vs alpha 2-adrenoceptor agonists (e.g., clonidine)
Design
Review
Authors
Loading...
Does not alter management; leaves open therapeutic targeting of 5-HT1A receptors in autonomic cardiovascular disorders.
5-HT1A receptor agonists modulate central cardiovascular pathways by causing differential sympathoinhibition and increasing cardiac vagal drive.
Andrew G. Ramage (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: